🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Substudy 02B is part of a larger research study where researchers are looki...
Status
Completed
Location
The Angeles Clinic and Research Institute ( Site 2009)
Start Date
2020-07-01
Trial ID
NCT04305054
Treatments Being Tested
Substudy 03A is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 1008)
Start Date
2020-12-16
Trial ID
NCT04626479
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573
Substudy 02C is part of a larger research study that is testing experimenta...
Status
Completed
Location
The Angeles Clinic and Research Institute ( Site 3009)
Start Date
2020-06-26
Trial ID
NCT04303169
Treatments Being Tested
The main purpose of this study is to compare pembrolizumab/vibostolimab cof...
Status
Completed
Location
Cedars-Sinai Medical Center ( Site 2522)
Start Date
2021-04-20
Trial ID
NCT04725188
Treatments Being Tested
The purpose of the study is to determine the safety and tolerability of pem...
Status
Completed
Location
City of Hope Comprehensive Cancer Center-Hematology ( Site 0024)
Start Date
2021-09-28
Trial ID
NCT05005442
Treatments Being Tested
This study is a substudy being conducted under one pembrolizumab umbrella m...
Status
Active Not Recruiting
Location
Moores Cancer Center ( Site 3028)
Start Date
2023-06-23
Trial ID
NCT05845814
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pembroliz...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0001)
Start Date
2019-12-19
Trial ID
NCT04165070
This study will evaluate the combination of a fixed dose pembrolizumab/vibo...
Status
Active Not Recruiting
Location
Infirmary Cancer Care ( Site 0022)
Start Date
2022-03-24
Trial ID
NCT05224141
In this study, participants with high risk non-muscle-invasive bladder canc...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-10
Trial ID
NCT02625961
Treatments Being Tested